drug
METADATE ER
Marketedupdated 3mo agoby Lannett Co Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval486 co-mentions · 201 sources
- drugMETADATE CD462 co-mentions · 206 sources
- drugRITALIN LA273 co-mentions · 206 sources
- drugQuillivant XR262 co-mentions · 206 sources
- drugMethylin261 co-mentions · 206 sources
- drugMETHYLIN ER261 co-mentions · 206 sources
- drugmethylphenidate hydrochloride ER253 co-mentions · 206 sources
- drugRelexxii251 co-mentions · 206 sources
all catalysts(42)
approval · 42
Jun 1, 1988
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Jan 21, 1994
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Aug 25, 1994
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Sep 11, 1995
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Jul 2, 1996
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Feb 13, 1998
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Dec 8, 1998
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Dec 8, 1998
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Feb 22, 1999
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Oct 20, 1999
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Oct 20, 1999
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Nov 8, 1999
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
May 1, 2000
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Oct 23, 2001
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Oct 9, 2002
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Oct 9, 2002
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Dec 9, 2002
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Dec 9, 2002
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Dec 28, 2005
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Dec 28, 2005
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Aug 31, 2011
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Jan 21, 2016
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Jan 21, 2016
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Jan 21, 2016
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Jan 21, 2016
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Jan 21, 2016
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Jan 21, 2016
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Jan 21, 2016
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Jan 21, 2016
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Jan 21, 2016
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Jan 21, 2016
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Jan 21, 2016
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Jan 21, 2016
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Jan 21, 2016
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Jan 21, 2016
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Jan 21, 2016
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Jun 9, 2021
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Jun 9, 2021
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Jun 25, 2021
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Jun 25, 2021
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Oct 2, 2025
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Oct 2, 2025
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Trials studying METADATE ER
- phase3Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHD
- phase1Dexmethylphenidate Hydrochloride Tablets Under Fasting Conditions
- phase1Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting Conditions
- phase4A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity
Patent cliff
source: FDA Orange Bookfirst barrier falls
Mar 15, 2027
207 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (102)
- Nov 19, 2038method-of-use (U-2357)US 10722473
- Nov 19, 2038method-of-use (U-2357)US 10722473
- Nov 19, 2038method-of-use (U-2357)US 10722473
- Nov 19, 2038method-of-use (U-2357)US 10722473
- Nov 19, 2038method-of-use (U-2357)US 10722473
- Nov 19, 2038method-of-use (U-2357)US 10722473
- Oct 30, 2035method-of-use (U-2357)US 10111839
- Oct 30, 2035method-of-use (U-2357)US 10111839
- Oct 30, 2035method-of-use (U-2357)US 10111839
- Oct 30, 2035method-of-use (U-2357)US 10111839
- Oct 30, 2035method-of-use (U-2357)US 10111839
- Oct 30, 2035method-of-use (U-2357)US 10111839
- Oct 30, 2035formulationUS 10292938
- Oct 30, 2035formulationUS 10292938
- Oct 30, 2035formulationUS 10292938
- Oct 30, 2035formulationUS 10292938
- Oct 30, 2035formulationUS 10292938
- Oct 30, 2035formulationUS 10292938
- Oct 30, 2035formulationUS 10292939
- Oct 30, 2035formulationUS 10292939
- Oct 30, 2035formulationUS 10292939
- Oct 30, 2035formulationUS 10292939
- Oct 30, 2035formulationUS 10292939
- Oct 30, 2035formulationUS 10292939
- Oct 30, 2035method-of-use (U-2357)US 10449159
- Oct 30, 2035method-of-use (U-2357)US 10449159
- Oct 30, 2035method-of-use (U-2357)US 10449159
- Oct 30, 2035method-of-use (U-2357)US 10449159
- Oct 30, 2035method-of-use (U-2357)US 10449159
- Oct 30, 2035method-of-use (U-2357)US 10449159
- Oct 30, 2035method-of-use (U-2357)US 10500162
- Oct 30, 2035method-of-use (U-2357)US 10500162
- Oct 30, 2035method-of-use (U-2357)US 10500162
- Oct 30, 2035method-of-use (U-2357)US 10500162
- Oct 30, 2035method-of-use (U-2357)US 10500162
- Oct 30, 2035method-of-use (U-2357)US 10500162
- Oct 30, 2035formulationUS 10507186
- Oct 30, 2035formulationUS 10507186
- Oct 30, 2035formulationUS 10507186
- Oct 30, 2035formulationUS 10507186
- Oct 30, 2035formulationUS 10507186
- Oct 30, 2035formulationUS 10507186
- Oct 30, 2035formulationUS 10512612
- Oct 30, 2035formulationUS 10512612
- Oct 30, 2035formulationUS 10512612
- Oct 30, 2035formulationUS 10512612
- Oct 30, 2035formulationUS 10512612
- Oct 30, 2035formulationUS 10512612
- Oct 30, 2035method-of-use (U-2357)US 10512613
- Oct 30, 2035method-of-use (U-2357)US 10512613
- Oct 30, 2035method-of-use (U-2357)US 10512613
- Oct 30, 2035method-of-use (U-2357)US 10512613
- Oct 30, 2035method-of-use (U-2357)US 10512613
- Oct 30, 2035method-of-use (U-2357)US 10512613
- Oct 30, 2035formulationUS 10568841
- Oct 30, 2035formulationUS 10568841
- Oct 30, 2035formulationUS 10568841
- Oct 30, 2035formulationUS 10568841
- Oct 30, 2035formulationUS 10568841
- Oct 30, 2035formulationUS 10568841
- Oct 30, 2035formulationUS 10688060
- Oct 30, 2035formulationUS 10688060
- Oct 30, 2035formulationUS 10688060
- Oct 30, 2035formulationUS 10688060
- Oct 30, 2035formulationUS 10688060
- Oct 30, 2035formulationUS 10688060
- Oct 30, 2035formulationUS 9974752
- Oct 30, 2035formulationUS 9974752
- Oct 30, 2035formulationUS 9974752
- Oct 30, 2035formulationUS 9974752
- Oct 30, 2035formulationUS 9974752
- Oct 30, 2035formulationUS 9974752
- Aug 14, 2033formulationUS 10857143
- Aug 14, 2033formulationUS 10857143
- Aug 14, 2033formulationUS 10857143
- Aug 14, 2033formulationUS 11103494
- Aug 14, 2033formulationUS 11103494
- Aug 14, 2033formulationUS 11103494
- Aug 14, 2033formulationUS 11103495
- Aug 14, 2033formulationUS 11103495
- Aug 14, 2033formulationUS 11103495
- Aug 14, 2033formulationUS 11633389
- Aug 14, 2033formulationUS 11633389
- Aug 14, 2033formulationUS 11633389
- Aug 14, 2033formulationUS 8999386
- Aug 14, 2033formulationUS 8999386
- Aug 14, 2033formulationUS 8999386
- Aug 14, 2033formulationUS 9295642
- Aug 14, 2033formulationUS 9295642
- Aug 14, 2033formulationUS 9295642
- Aug 14, 2033formulationUS 9545399
- Aug 14, 2033formulationUS 9545399
- Aug 14, 2033formulationUS 9545399
- Aug 14, 2033formulationUS 9844544
- Aug 14, 2033formulationUS 9844544
- Aug 14, 2033formulationUS 9844544
- Feb 15, 2031formulationUS 82879034.5y
- Feb 15, 2031formulationUS 82879034.5y
- Feb 15, 2031formulationUS 82879034.5y
- Mar 15, 2027formulationUS 8202537207d
- Mar 15, 2027formulationUS 8202537207d
- Mar 15, 2027formulationUS 8202537207d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 30m ago
Found something off?
comments(0)
5-min edit window · permanent after that